Samsung Electronics Co., Ltd.

Seungja Oh

Kyung Ah Kim

Bo Gyou Kim

Seung Hyun Lee

Ji Min Lee

Powei Lin

Saet Byoul Lee

Jimin Lee

A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met and EGFR (hereinafter, 'c-Met/EGFR dual inhibitor') and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met/EGFR dual inhibitor.

Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor

An anti-c-Met/anti-Ang2 bispecific antibody including (a) an anti-c-Met antibody or antigen-binding fragment thereof and (b) an anti-Ang2 antibody or antigen-binding fragment thereof, a pharmaceutical composition including the anti-c-Met/anti-Ang2 bispecific antibody, and a method using the anti-c-Met/anti-Ang2 bispecific antibody.

Anti-c-Met/anti-Ang2 bispecific antibody

Growing community of inventors

Hwaseong-si, South Korea

Seungja Oh